Uridine allows dose escalation of 5-fluorouracil when given with N-phosphonacetyl-L-Aspartate, methotrexate, and leucovorin
- 1 March 1993
- Vol. 71 (5) , 1875-1881
- https://doi.org/10.1002/1097-0142(19930301)71:5<1875::aid-cncr2820710526>3.0.co;2-9
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Clinical and Pharmacologic Study of Orally Administrated UridineJNCI Journal of the National Cancer Institute, 1991
- Enhancement of the antitumor activity of 5-fluorouracil by uridine rescuePharmacology & Therapeutics, 1989
- Reversal of 5-Fluorouracil-Induced Myelosuppression by Prolonged Administration of High-Dose UridineJNCI Journal of the National Cancer Institute, 1989
- In vitro biochemical and in vivo biological studies of the uridine 'rescue' of 5-fluorouracilBritish Journal of Cancer, 1988
- Role of chemotherapy in the treatment of colorectal carcinomaSeminars in Surgical Oncology, 1987
- Uridine rescue from the lethal toxicity of 5-fluorouracil in miceCancer Chemotherapy and Pharmacology, 1982
- Synergistic effect of 5-fluorouracil and N-(phosphonacetyl)-l-aspartate on cell growth and ribonucleic acid synthesis in a human mammary carcinomaBiochemical Pharmacology, 1981
- Reporting results of cancer treatmentCancer, 1981
- Enhanced 5-Fluorouracil Nucleotide Formation After Methotrexate Administration: Explanation for Drug SynergismScience, 1979